106 related articles for article (PubMed ID: 8762431)
1. [A study of P53 protein expression in fibrous neoplasms].
Li J; Yang G; Li G
Zhonghua Bing Li Xue Za Zhi; 1996 Feb; 25(1):7-9. PubMed ID: 8762431
[TBL] [Abstract][Full Text] [Related]
2. Dermatofibrosarcoma protuberans: an analysis of proliferative activity, DNA flow cytometry and p53 overexpression with emphasis on its progression.
Sasaki M; Ishida T; Horiuchi H; MacHinami R
Pathol Int; 1999 Sep; 49(9):799-806. PubMed ID: 10504551
[TBL] [Abstract][Full Text] [Related]
3. [Detection of point mutation of p53 gene by silver staining PCR-SSCP in paraffin-embedded malignant fibrous histiocytoma].
Li J; Yang G; Li G
Zhonghua Zhong Liu Za Zhi; 1996 Jan; 18(1):13-5. PubMed ID: 8732103
[TBL] [Abstract][Full Text] [Related]
4. [Fibrosarcomatous dermatofibrosarcoma protuberans: a clinicopathological analysis of 12 cases].
Zhang J; Wu N; Xia C; Wei X; Shi QL; Zhou XJ; Ma J
Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):753-7. PubMed ID: 24447553
[TBL] [Abstract][Full Text] [Related]
5. Dermatofibrosarcoma protuberans with fibrosarcomatous areas. Molecular abnormalities of the p53 pathway in fibrosarcomatous transformation of dermatofibrosarcoma protuberans.
Hisaoka M; Okamoto S; Morimitsu Y; Tsuji S; Hashimoto H
Virchows Arch; 1998 Oct; 433(4):323-9. PubMed ID: 9808434
[TBL] [Abstract][Full Text] [Related]
6. A progression to dermatofibrosarcoma protuberans with a fibrosarcomatous component: a special reference to the chromosomal aberrations.
Hamada M; Hirakawa N; Fukuda T; Furue M; Hori Y; Tsuneyoshi M
Pathol Res Pract; 1999; 195(7):451-60. PubMed ID: 10448661
[TBL] [Abstract][Full Text] [Related]
7. p53 protein immunoreactivity in fibrohistiocytic tumors of the skin.
Lee CS; Chou ST
Pathology; 1998 Aug; 30(3):272-5. PubMed ID: 9770192
[TBL] [Abstract][Full Text] [Related]
8. Expression of COL1A1-PDGFB fusion transcripts in superficial adult fibrosarcoma suggests a close relationship to dermatofibrosarcoma protuberans.
Sheng WQ; Hashimoto H; Okamoto S; Ishida T; Meis-Kindblom JM; Kindblom LG; Hisaoka M
J Pathol; 2001 May; 194(1):88-94. PubMed ID: 11329146
[TBL] [Abstract][Full Text] [Related]
9. nm23 protein expression and p53 immunoreactivity in cutaneous fibrohistiocytic tumors.
Lee CS; Clarke RA; Tran KT; Kearsley JH; Chou ST
Pathology; 1999 May; 31(2):123-6. PubMed ID: 10399167
[TBL] [Abstract][Full Text] [Related]
10. Tenascin expression in cutaneous fibrohistiocytic tumors. Immunohistochemical investigation of 24 cases.
Franchi A; Santucci M
Am J Dermatopathol; 1996 Oct; 18(5):454-9. PubMed ID: 8902090
[TBL] [Abstract][Full Text] [Related]
11. The expression levels and the differential expression of transforming growth factor-beta receptors in dermatofibroma and dermatofibrosarcoma protuberans.
Kubo M; Ihn H; Yamane K; Tamaki K
Br J Dermatol; 2006 May; 154(5):919-25. PubMed ID: 16634896
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of platelet-derived growth factor and its receptors in fibrohistiocytic tumors.
Taniuchi K; Yamada Y; Nonomura A; Takehara K
J Cutan Pathol; 1997 Aug; 24(7):393-7. PubMed ID: 9274955
[TBL] [Abstract][Full Text] [Related]
13. A study of CD117 expression in dermatofibrosarcoma protuberans and cellular dermatofibroma.
Labonte S; Hanna W; Bandarchi-Chamkhaleh B
J Cutan Pathol; 2007 Nov; 34(11):857-60. PubMed ID: 17944726
[TBL] [Abstract][Full Text] [Related]
14. Comparison of p53 expression in dermatofibrosarcoma protuberans and dermatofibroma: lack of correlation with proliferation rate.
Díaz-Cascajo C; Bastida-Iñarrea J; Borrego L; Carretero-Hernández G
J Cutan Pathol; 1995 Aug; 22(4):304-9. PubMed ID: 7499569
[TBL] [Abstract][Full Text] [Related]
15. Immunoexpression of ultraviolet photoproducts and p53 mutation analysis in atypical fibroxanthoma and superficial malignant fibrous histiocytoma.
Sakamoto A; Oda Y; Itakura E; Oshiro Y; Nikaido O; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2001 Jun; 14(6):581-8. PubMed ID: 11406660
[TBL] [Abstract][Full Text] [Related]
16. Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and factor XIIIa.
Kahn HJ; Fekete E; From L
Hum Pathol; 2001 Jan; 32(1):50-6. PubMed ID: 11172295
[TBL] [Abstract][Full Text] [Related]
17. The Immunological Roles of Periostin/Tumor-Associated Macrophage Axis in Development of Dermatofibrosarcoma Protuberans.
Fujimura T; Kakizaki A; Sato Y; Tanita K; Furudate S; Aiba S
Anticancer Res; 2017 Jun; 37(6):2867-2873. PubMed ID: 28551623
[TBL] [Abstract][Full Text] [Related]
18. Histiocyte-like cells expressing factor XIIIa do not belong to the neoplastic cell population in malignant fibrous histiocytoma.
Szollosi Z; Nemeth T; Egervari K; Nemes Z
Pathol Res Pract; 2005; 201(5):369-77. PubMed ID: 16047946
[TBL] [Abstract][Full Text] [Related]
19. Dermatofibroma and dermatofibrosarcoma protuberans: differential expression of CD34 and factor XIIIa.
Cohen PR; Rapin RP; Farhood AI
Am J Dermatopathol; 1994 Oct; 16(5):573-4. PubMed ID: 7528477
[No Abstract] [Full Text] [Related]
20. Microvessel density and HIF-1alpha expression correlate with malignant potential in fibrohistiocytic tumors.
Koga K; Nabeshima K; Nishimura N; Shishime M; Nakayama J; Iwasaki H
Eur J Dermatol; 2005; 15(6):465-9. PubMed ID: 16280300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
